The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zavadenko N.N.

Kafedra nevrologii i neĭrokhirurgii pediatricheskogo fakulteta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Khondkaryan G.Sh.

Pirogov Russian National Research Medical University of the Russian Federation Ministry of Health, Moscow, Russia

Bembeeva R.Ts.

Pirogov Russian National Research Medical University, Moscow

Kholin A.A.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Saverskaya E.N.

Institute of Medical and Social Technologies, Moscow State University of Food Production, Moscow, Russia

Human prion diseases: current issues

Authors:

Zavadenko N.N., Khondkaryan G.Sh., Bembeeva R.Ts., Kholin A.A., Saverskaya E.N.

More about the authors

Read: 35916 times


To cite this article:

Zavadenko NN, Khondkaryan GSh, Bembeeva RTs, Kholin AA, Saverskaya EN. Human prion diseases: current issues. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(6):88‑95. (In Russ.)
https://doi.org/10.17116/jnevro20181186188

Recommended articles:
Current approaches to the prevention and treatment of post-thrombotic syndrome. Russian Journal of Preventive Medi­cine. 2025;(5):111-116
Portopulmonary hype­rtension. Journal of Respiratory Medi­cine. 2025;(2):39-44
Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33

References:

  1. Mutovin GR. Clinical genetics. Genomics and proteomics in hereditary diseases. Moscow: GEOTAR-media; 2010. (In Russ.)
  2. Peresedova AV, Zavalishin IA. Creutzfeldt—Jakob disease: current issues (review). Annals of Clinical and Experimental Neurology. 2012;(1):57-63. (In Russ.)
  3. Zuev VA. Prions as a particular type of slow infections agents in human and animals. RMJ. 2013;30:1559-1566. (In Russ.)
  4. Araújo AQ. Prionic diseases. Arq Neuropsiquiatr. 2013;71(9B):731-737.
  5. Dameron M. Rapid cognitive and functional decline: Creutzfeldt—Jakob disease. JAAPA. 2013;26(9):pii:01720610-201309000-00017 https://doi.org/10.1097/01.JAA.0000433963.28385.db
  6. Alper T, Cramp WA, Haig DA, Clarke MC. Does the agent of scrapie replicate without nucleic acid? Nature. 1967;214(5090):764-766. https://doi.org/10.1038/214764a0
  7. Griffith JS. Self-replication and scrapie. Nature. 1967;215(5105):1043-1044. https://doi.org/10.1038/2151043a0
  8. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216(4542):136-144.
  9. Prusiner SB. Prions. Proc Natl Acad Sci USA. 1998;95(23):13363-13383. https://doi.org/10.1073/pnas.95.23.13363
  10. Yusa S, Oliveira-Martins JB, Sugita-Konishi Y, Kikuchi Y. Cellular prion protein: from physiology to pathology. Viruses. 2012;4(11):3109-3131. https://doi.org/10.3390/v4113109
  11. Mead S. Prion disease genetics. Eur J Hum Genet. 2006;14:273-281. https://doi.org/10.1038/sj.ejhg.5201544
  12. Zerr I, Polyakova TA. Creutzfeldt-Jakob disease: clinical and diagnostic aspects. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(6, 2):9-16. (In Russ.) https://doi.org/10.17116/jnevro2015115629-16
  13. Málaga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L, Thomanetz V, Stuermer CAO. Regulation of embryonic cell adhesion by the prion protein. PLoS Biology. 2009;7(3):55. https://doi.org/10.1371/journal.pbio.1000055
  14. Grassmann A, Wolf H, Hofmann J, Graham J, Vorberg I. Cellular aspects of prion replication in vitro. Viruses. 2013;5(1):374-405. https://doi.org/10.3390/v5010374
  15. Manix M, Kalakoti P, Henry M, Thakur J, Menger R, Guthikonda B, Nanda A. Creutzfeldt—Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus. 2015;39(5):2:1-11. https://doi.org/10.3171/2015.8.FOCUS15328
  16. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG. Possible transmission of variant Creutzfeldt—Jakob disease by blood transfusion. Lancet. 2004;363:417-421. https://doi.org/10.1016/S0140-6736(04)15486-X
  17. Shlomchik MJ, Radebold K, Duclos N, Manuelidis L. Neuroinvasion by a Creutzfeldt—Jakob disease agent in the absence of B cells and follicular dendritic cells. Proc Natl Acad Sci USA. 2001;98(16):9289-9294. https://doi.org/10.1073/pnas.161055198
  18. Nicoll AJ, Collinge J. Preventing prion pathogenicity by targeting the cellular prion protein. Infect Disord Drug Targets. 2009;9(1):48-57.
  19. Zuev VA, Zavalishin IA, Roikhel’ VM. Prion diseases of humans and animals. M.: Meditsina; 1999. (In Russ.)
  20. Gough KC, Maddison BC. Prion transmission. Prion. 2010;4(4):275-782.
  21. Boychenko MN, Volchkova YeV, Pak SG. Biological preparations and prion diseases: whether etiological êelation is possible? International Neurological Journal. 2014;6(68):77-84. (In Russ.)
  22. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annual Review of Neuroscience. 2001;24:519-550. https://doi.org/10.1146/annurev.neuro.24.1.519
  23. Mader EC Jr, El-Abassi R, Villemarette-Pittman NR, Santana-Gould L, Olejniczak PW, England JD. Sporadic Creutzfeldt—Jakob disease with focal findings: caveats to current diagnostic criteria. Neurol Int. 2013;15:5(1):1. https://doi.org/10.4081/ni.2013.e1
  24. Maltête D, Maréchal G, Mihout B, Hannequin D. Movement disorders and Creutzfeld—Jakob disease: a review. Parkinsonism and Related Disorders. 2006;12(2):65-71. https://doi.org/10.1016/j.parkreldis.2005.10.004
  25. Krasnianski A, Bohling GT, Harden M, Zerr I. Psychiatric symptoms in patients with sporadic Creutzfeldt—Jakob disease in Germany. Journal of Clinical Psychiatry. 2015;76(9):1209-1215. https://doi.org/10.4088/JCP.13m08915
  26. Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt—Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012;79:1499-1506. https://doi.org/10.1212/WNL.0b013e31826d5fc3
  27. Power B, Trivedi D, Samuel M. What psychiatrists should know about sporadic Creutzfeldt—Jakob disease. Australasian Psychiatry. 2012;20(1):61-66. https://doi.org/10.1177/1039856211430145
  28. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG. Possible transmission of variant Creutzfeldt—Jakob disease by blood transfusion. Lancet. 2004;363:417-421. https://doi.org/10.1016/S0140-6736(04)15486-X
  29. Collinge J. Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genet. 1997;6(10):1699-1705. https://doi.org/10.1093/hmg/6.10.1699
  30. Bateman D, Hilton D, Love S, Zeidler M, Beck J, Collinge J. Sporadic Creutzfeldt—Jakob disease in a 18-year-old in the UK. Lancet. 1995; 346(8983):1155-1156.
  31. Britton TC, al-Sarraj S, Shaw C, Campbell T, Collinge J. Sporadic Creutzfeldt—Jakob disease in a 16-year-old in the UK. Lancet. 1995; 346(8983): 1155.
  32. Soomro S, Mohan Ch. Biomarkers for sporadic Creutzfeldt—Jakob disease. Annals of Clinical and Translational Neurology. 2016;3(6):465-472. https://doi.org/10.1002/acn3.304
  33. Imran M, Mahmood S. An overview of human prion diseases. Virol J. 2011;8:559. https://doi.org/10.1186/1743-422X-8-559
  34. Gambetti P, Puoti G, Zou WQ. Variably protease-sensitive prionopathy: a novel disease of the prion protein. J Mol Neurosci. 2011;45(3):422-424. https://doi.org/10.1007/s12031-011-9543-1
  35. Blase JL, Cracco L, Schonberger LB, Maddox RA, Cohen Y, Cali I, Belay ED. Sporadic Fatal Insomnia in an Adolescent. Pediatrics. 2014;133(3):766-770. https://doi.org/10.1542/peds.2013-1396
  36. Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Campbell T, Al-Dujaily H, Hummerich H, Beck J, Mein CA, Verzilli C, Whittaker J, Alpers MP, Collinge J. A Novel Protective Prion Protein Variant that Colocalizes with Kuru Exposure. N Engl J Med. 2009;361(21):2056-2065. https://doi.org/10.1056/NEJMoa0809716
  37. Mead S, Gandhi S, Collinge J, Caine D, Gallujipali D, Carswell Ch, Hyare H, Joiner S, Ayling H, Lashley T, Linehan JM, Al-Doujaily H, Sharps B, Revesz T, Sandberg MK, Reilly MM, Koltzenburg M, Forbes A, Rudge P, Brandner S, Warren JD, Wadsworth JDF, Wood NW, Holton JL, Collinge J. A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med. 2013;369(20):1904-1914. https://doi.org/10.1056/NEJMoa1214747
  38. Müller-Schiffmann A, Korth C.Vaccine approaches to prevent and treat prion infection: progress and challenges. BioDrugs. 2008;22(1):45-52.
  39. Race RE, Raymond GJ. Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH. Journal of Virology. 2004;78(4):2164-2165. https://doi.org/10.1128/JVI.78.4.2164-2165.2004
  40. Collins SJ, Lawson VA, Masters CL. Transmissible spongiform encephalopathies. Lancet. 2004;363(9402):51-61. https://doi.org/10.1016/S0140-6736(03)15171-9
  41. Dinga N, Neumann NF, Priceb LM, Braithwaiteb ShL, Balachandrand A, Mitchelld G, Belosevic M, El-Dina MG. Kinetics of Ozone Inactivation of Infectious Prion Protein. Appl Environ Microbiol. 2013;79(8):2721-2730. https://doi.org/10.1128/AEM.03698-12
  42. Huyben D, Boqvist S, Passoth V, Renström L, Allard Bengtsson U, Andréoletti O, Kiessling A, Lundh T, Vågsholm I. Screening of intact yeasts and cell extracts to reduce Scrapie prions during biotransformation of food waste. Acta Vet Scand. 2018;60(1):1-9. https://doi.org/10.1186/s13028-018-0363-y

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.